NUMAFERM is a spin-off company from the Institute of Biochemistry, Heinrich-Heine-University Duesseldorf. The cornerstone of NUMAFERM’s IP was laid by Dr. Christian Schwarz and Dr. Sander Smits, chaired by Prof. Dr. Lutz Schmitt. Following several pre-seed projects, for example „EXIST-Forschungstransfer“ funded by the German Ministry of Economic Affairs and Energy and “Ideenwettbewerb” of the German Ministry of Education and Research, NUMAFERM was incorporated as GmbH in January 2017. Since then, NUMAFERM closed its seed financing round. Amongst the investors are QIAGEN’s co-founders Prof. em. Dr. Dr. h.c. Detlev Riesner and Dr. Jürgen Schumacher, High-Tech-Gründerfonds, European Investment Fund and Evonik Venture Capital.